209 related articles for article (PubMed ID: 22037979)
1. Intravenous tissue plasminogen activator treatment for ischemic stroke in dabigatran-treated patients.
Takeuchi S; Wada K; Nagatani K; Otani N; Osada H; Nawashiro H
Acta Neurochir (Wien); 2012 Jan; 154(1):87. PubMed ID: 22037979
[No Abstract] [Full Text] [Related]
2. Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke.
Pfeilschifter W; Bohmann F; Baumgarten P; Mittelbronn M; Pfeilschifter J; Lindhoff-Last E; Steinmetz H; Foerch C
Ann Neurol; 2012 May; 71(5):624-33. PubMed ID: 22447744
[TBL] [Abstract][Full Text] [Related]
3. Dilemma of indication for thrombolysis in a patient with acute ischemic stroke treated with a novel oral anticoagulant.
Folyovich A; Varga V; Béres-Molnár KA; Vadasdi K; Bereczki D
J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):580-2. PubMed ID: 23721623
[TBL] [Abstract][Full Text] [Related]
4. Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with dabigatran.
De Smedt A; De Raedt S; Nieboer K; De Keyser J; Brouns R
Cerebrovasc Dis; 2010; 30(5):533-4. PubMed ID: 20881383
[No Abstract] [Full Text] [Related]
5. Fatal intracerebral hemorrhage associated with administration of recombinant tissue plasminogen activator in a stroke patient on treatment with dabigatran.
Casado Naranjo I; Portilla-Cuenca JC; Jiménez Caballero PE; Calle Escobar ML; Romero Sevilla RM
Cerebrovasc Dis; 2011; 32(6):614-5. PubMed ID: 22133608
[No Abstract] [Full Text] [Related]
6. Dabigatran and thrombolysis: A therapeutic dilemma.
Govindarajan R; Salgado E
Ann Neurol; 2012 Oct; 72(4):625; author reply 625-6. PubMed ID: 23109156
[No Abstract] [Full Text] [Related]
7. Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke.
Prabhakaran S; Rivolta J; Vieira JR; Rincon F; Stillman J; Marshall RS; Chong JY
Arch Neurol; 2010 May; 67(5):559-63. PubMed ID: 20212195
[TBL] [Abstract][Full Text] [Related]
8. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ
Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238
[TBL] [Abstract][Full Text] [Related]
9. Reducing hemorrhagic complication by dabigatran via neurovascular protection after recanalization with tissue plasminogen activator in ischemic stroke of rat.
Kono S; Deguchi K; Omote Y; Yunoki T; Yamashita T; Kurata T; Ikeda Y; Abe K
J Neurosci Res; 2014 Jan; 92(1):46-53. PubMed ID: 24265137
[TBL] [Abstract][Full Text] [Related]
10. Fibrinolytic treatment of acute ischemic stroke for patients on new oral anticoagulant drugs.
Dempfle CE; Hennerici MG
Cerebrovasc Dis; 2011; 32(6):616-9. PubMed ID: 22133643
[No Abstract] [Full Text] [Related]
11. Proposed approach to thrombolysis in dabigatran-treated patients presenting with ischemic stroke.
Kate M; Szkotak A; Witt A; Shuaib A; Butcher K
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1351-5. PubMed ID: 24406026
[TBL] [Abstract][Full Text] [Related]
12. Role of tissue plasminogen activator in acute ischemic stroke.
Hatcher MA; Starr JA
Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of acute ischemic apoplexy].
Andersen G; Krieger DW; Iversen HK
Ugeskr Laeger; 2009 Mar; 171(13):1094. PubMed ID: 19321089
[No Abstract] [Full Text] [Related]
14. Treating as early as possible with thrombolysis is crucial, but can we do better in the sub-4.5-hour time window?
Parsons MW
Cerebrovasc Dis; 2011; 31(3):229. PubMed ID: 21178346
[No Abstract] [Full Text] [Related]
15. Treatment of acute ischemic stroke: intravenous and endovascular therapies.
Jahan R; Vinuela F
Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):375-87. PubMed ID: 19379062
[TBL] [Abstract][Full Text] [Related]
16. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes.
Fonarow GC; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Grau-Sepulveda MV; Olson DM; Hernandez AF; Peterson ED; Schwamm LH
Circulation; 2011 Feb; 123(7):750-8. PubMed ID: 21311083
[TBL] [Abstract][Full Text] [Related]
17. Thrombolysis in an ischemic stroke patient on dabigatran anticoagulation: a case report.
Marrone LC; Marrone AC
Cerebrovasc Dis; 2012; 34(3):246-7. PubMed ID: 23018342
[No Abstract] [Full Text] [Related]
18. [Pharmacological sheet. Dabigatran, oral administration (Pradaxa)].
Duh PD; Leuckx PS; Warnez PM
J Pharm Belg; 2012 Mar; (1):37-8. PubMed ID: 22536682
[No Abstract] [Full Text] [Related]
19. Place of dabigatran in contemporary pharmacotherapy.
Gums JG
Pharmacotherapy; 2011 Apr; 31(4):335-7. PubMed ID: 21449622
[No Abstract] [Full Text] [Related]
20. [Prevention of cardioembolic stroke].
Gil Núñez A
Neurologia; 2012 Mar; 27 Suppl 1():15-26. PubMed ID: 22682206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
